• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

检查点受体2B4在传统和嵌合抗原受体T细胞中构建的双相信号小体的成像。

Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells.

作者信息

Matsushima Ryohei, Wakamatsu Ei, Machiyama Hiroaki, Nishi Wataru, Yoshida Yosuke, Nishikawa Tetsushi, Toyota Hiroko, Furuhata Masae, Nishijima Hitoshi, Takeuchi Arata, Suzuki Makoto, Yokosuka Tadashi

机构信息

Department of Thoracic Surgery, Graduate School of Medical Sciences, Kumamoto University, Kumamoto 860-8556, Japan.

Department of Immunology, Tokyo Medical University, Tokyo 160-8402, Japan.

出版信息

iScience. 2024 Dec 21;28(1):111669. doi: 10.1016/j.isci.2024.111669. eCollection 2025 Jan 17.

DOI:10.1016/j.isci.2024.111669
PMID:39886466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11780131/
Abstract

A co-signaling receptor, 2B4, has dual effects in immune cells, but its actual functions in T cells remain elusive. Here, using super-resolution imaging technology with an immunological synapse model, we showed that 2B4 forms "2B4 microclusters" immediately after 2B4-CD48 binding. A lipid phosphatase, SHIP-1, subsequently combined with 2B4 to form coinhibitory signalosomes, leading to the suppression of cytokine production. An activating adapter, SLAM-associated protein (SAP), attenuated the clustering of SHIP-1 and recruited a kinase, Fyn, enhancing the Vav1 signaling pathway as costimulatory signalosomes. Furthermore, we found that a chimeric antigen receptor with a 2B4 tail (2B4-CAR) retained the original signal transduction mechanism of 2B4. With endogenous levels of SAP expression, 2B4-CAR-T cells exposed sufficient antitumor efficacy without excess cytokine production. Our results may help explain the biphasic feature of 2B4 in T cell responses from the viewpoint of the signalosome and provide a new candidate for CAR development.

摘要

共信号受体2B4在免疫细胞中具有双重作用,但其在T细胞中的实际功能仍不清楚。在这里,我们使用超分辨率成像技术结合免疫突触模型,发现2B4与CD48结合后立即形成“2B4微簇”。脂质磷酸酶SHIP-1随后与2B4结合形成共抑制信号小体,导致细胞因子产生受到抑制。激活适配器——信号淋巴细胞激活分子相关蛋白(SAP),减弱SHIP-1的聚集并招募激酶Fyn,作为共刺激信号小体增强Vav1信号通路。此外,我们发现带有2B4尾巴的嵌合抗原受体(2B4-CAR)保留了2B4原有的信号转导机制。在内源性SAP表达水平下,2B4-CAR-T细胞展现出足够的抗肿瘤功效且不会产生过量细胞因子。我们的研究结果可能有助于从信号小体的角度解释2B4在T细胞反应中的双相特征,并为嵌合抗原受体的开发提供新的候选对象。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/de0fbfd46537/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/f2229d0b1597/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/b41516d0dbe8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/1c54f5137c41/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/546d854e25fe/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/dfbcbcaaac16/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/f61ca4b94133/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/de0fbfd46537/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/f2229d0b1597/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/b41516d0dbe8/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/1c54f5137c41/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/546d854e25fe/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/dfbcbcaaac16/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/f61ca4b94133/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6516/11780131/de0fbfd46537/gr6.jpg

相似文献

1
Imaging of biphasic signalosomes constructed by checkpoint receptor 2B4 in conventional and chimeric antigen receptor-T cells.检查点受体2B4在传统和嵌合抗原受体T细胞中构建的双相信号小体的成像。
iScience. 2024 Dec 21;28(1):111669. doi: 10.1016/j.isci.2024.111669. eCollection 2025 Jan 17.
2
2B4 costimulatory domain enhancing cytotoxic ability of anti-CD5 chimeric antigen receptor engineered natural killer cells against T cell malignancies.2B4 共刺激结构域增强了抗 CD5 嵌合抗原受体工程化自然杀伤细胞对 T 细胞恶性肿瘤的细胞毒性。
J Hematol Oncol. 2019 May 16;12(1):49. doi: 10.1186/s13045-019-0732-7.
3
2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.2B4 通过磷酸化细胞外信号相关激酶/ B 细胞淋巴瘤 2 信号通路抑制自然杀伤细胞的凋亡。
Cytotherapy. 2023 Oct;25(10):1080-1090. doi: 10.1016/j.jcyt.2023.07.002. Epub 2023 Jul 29.
4
DNAM1 and 2B4 Costimulatory Domains Enhance the Cytotoxicity of Anti-GPC3 Chimeric Antigen Receptor-Modified Natural Killer Cells Against Hepatocellular Cancer Cells in vitro.DNAM1和2B4共刺激结构域增强抗GPC3嵌合抗原受体修饰的自然杀伤细胞对肝癌细胞的体外细胞毒性。
Cancer Manag Res. 2020 May 8;12:3247-3255. doi: 10.2147/CMAR.S253565. eCollection 2020.
5
Molecular basis for positive and negative signaling by the natural killer cell receptor 2B4 (CD244).自然杀伤细胞受体2B4(CD244)正负信号传导的分子基础。
Blood. 2005 Jun 15;105(12):4722-9. doi: 10.1182/blood-2004-09-3796. Epub 2005 Feb 15.
6
Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4.调节自然杀伤细胞和T细胞反应的潜在途径:X连锁淋巴增殖综合征基因产物信号淋巴细胞激活分子相关蛋白(SAP)与信号淋巴细胞激活分子(SLAM)和2B4的差异相互作用
Int Immunol. 2000 Dec;12(12):1749-57. doi: 10.1093/intimm/12.12.1749.
7
Regulation of natural cytotoxicity by the adaptor SAP and the Src-related kinase Fyn.衔接蛋白SAP和Src相关激酶Fyn对自然细胞毒性的调节作用。
J Exp Med. 2005 Jul 4;202(1):181-92. doi: 10.1084/jem.20050449.
8
Molecular dissection of 2B4 signaling: implications for signal transduction by SLAM-related receptors.2B4信号传导的分子剖析:对与信号淋巴细胞激活分子相关受体的信号转导的影响
Mol Cell Biol. 2004 Jun;24(12):5144-56. doi: 10.1128/MCB.24.12.5144-5156.2004.
9
2B4 utilizes ITAM-containing receptor complexes to initiate intracellular signaling and cytolysis.2B4 通过利用含有 ITAM 的受体复合物来启动细胞内信号转导和细胞裂解。
Mol Immunol. 2011 May;48(9-10):1149-59. doi: 10.1016/j.molimm.2011.02.008. Epub 2011 Mar 25.
10
A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells.一种经过定制以整合互补激活信号的嵌合抗原受体可增强自然杀伤细胞的抗肿瘤活性。
J Exp Clin Cancer Res. 2025 Mar 6;44(1):86. doi: 10.1186/s13046-025-03351-5.

本文引用的文献

1
Evaluation of therapeutic PD-1 antibodies by an advanced single-molecule imaging system detecting human PD-1 microclusters.利用先进的单分子成像系统检测人 PD-1 微簇评估治疗性 PD-1 抗体。
Nat Commun. 2023 Jun 6;14(1):3157. doi: 10.1038/s41467-023-38512-7.
2
SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy.SLAM 家族受体作为癌症免疫治疗的潜在分子靶点崭露头角。
Front Immunol. 2023 May 11;14:1174138. doi: 10.3389/fimmu.2023.1174138. eCollection 2023.
3
Clathrin mediates both internalization and vesicular release of triggered T cell receptor at the immunological synapse.
网格蛋白介导触发型 T 细胞受体在免疫突触处的内化和小泡释放。
Proc Natl Acad Sci U S A. 2023 Feb 7;120(6):e2211368120. doi: 10.1073/pnas.2211368120. Epub 2023 Feb 2.
4
Expression of inducible factors reprograms CAR-T cells for enhanced function and safety.诱导因子的表达重编程 CAR-T 细胞以增强功能和安全性。
Cancer Cell. 2022 Dec 12;40(12):1470-1487.e7. doi: 10.1016/j.ccell.2022.11.006.
5
Cis interactions between CD2 and its ligands on T cells are required for T cell activation.CD2 与其在 T 细胞上的配体之间的顺式相互作用是 T 细胞激活所必需的。
Sci Immunol. 2022 Aug 5;7(74):eabn6373. doi: 10.1126/sciimmunol.abn6373.
6
Lisocabtagene maraleucel versus standard of care with salvage chemotherapy followed by autologous stem cell transplantation as second-line treatment in patients with relapsed or refractory large B-cell lymphoma (TRANSFORM): results from an interim analysis of an open-label, randomised, phase 3 trial.西达基奥仑赛对比挽救化疗后自体干细胞移植作为二线治疗复发或难治性大 B 细胞淋巴瘤患者的标准治疗(TRANSFORM):一项开放标签、随机、3 期临床试验的中期分析结果。
Lancet. 2022 Jun 18;399(10343):2294-2308. doi: 10.1016/S0140-6736(22)00662-6.
7
CAR T cell manufacturing from naive/stem memory T lymphocytes enhances antitumor responses while curtailing cytokine release syndrome.从幼稚/干细胞记忆 T 淋巴细胞中制造 CAR T 细胞可增强抗肿瘤反应,同时减少细胞因子释放综合征。
J Clin Invest. 2022 Jun 15;132(12). doi: 10.1172/JCI150807.
8
Engineering CAR-NK cells to secrete IL-15 sustains their anti-AML functionality but is associated with systemic toxicities.工程化 CAR-NK 细胞分泌 IL-15 可维持其抗 AML 功能,但与全身毒性有关。
J Immunother Cancer. 2021 Dec;9(12). doi: 10.1136/jitc-2021-003894.
9
Treatment-Related Adverse Events of Chimeric Antigen Receptor T-Cell (CAR T) in Clinical Trials: A Systematic Review and Meta-Analysis.嵌合抗原受体T细胞(CAR T)在临床试验中与治疗相关的不良事件:一项系统评价和荟萃分析
Cancers (Basel). 2021 Aug 3;13(15):3912. doi: 10.3390/cancers13153912.
10
Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study.西达基奥仑赛,一种针对 B 细胞成熟抗原的嵌合抗原受体 T 细胞疗法,用于治疗复发或难治性多发性骨髓瘤患者(CARTITUDE-1):一项 1b/2 期开放标签研究。
Lancet. 2021 Jul 24;398(10297):314-324. doi: 10.1016/S0140-6736(21)00933-8. Epub 2021 Jun 24.